ABL Sponsoring Atlantic Vaccines and Immunotherapeutics Summit

ABL Sponsoring Atlantic Vaccines and Immunotherapeutics Summit

  • May 7-8, 2015
  • Bethesda, Maryland

Bethesda, MD – May 7, 2015 – ABL is a sponsor of the Atlantic Vaccines and Immunotherapeutics Summit being held in Bethesda, Maryland on May 7-8. Government and industry leaders in the field of vaccines and immunotherapeutics will host discussions on the latest research and developments in the field.  Topics will include:

  • U.S. Government Priorities in Vaccine Research
  • Cancer Vaccines and Immunotherapeutics
  • Pandemic Flu Vaccines
  • Next Generation Technologies

Dr. Wenlin Zeng, Associate Director of Process Development at ABL, will give a talk titled “Transient Transfection: Accelerating Production of Vaccines and Therapeutics” on May 7 during the session titled “Advanced Manufacturing Strategies: Capacity, Development and Successes.”  ABL management and scientific staff will also be attending the conference to meet with potential collaborators and participate in discussions.  For more information or to schedule a meeting with ABL staff, please contact us.

About ABL, Inc.

ABL, Inc. is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics and other biologic products. ABL has extensive experience working with diverse organizations, including the U.S. Government, biopharmaceutical companies and academic entities. Notable contract manufacturing services include process and assay development, cGMP biologics manufacturing of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC analytics in the U.S. and Europe. ABL also maintains U.S. and European immunological and molecular laboratories to support preclinical and GCLP clinical sample processing and testing. ABL is a part of the Institut Mérieux, a group of companies dedicated to developing translational science for better patient care globally.

For more information visit www.ablinc.com or email us.